Journals / Eurasian Journal of Family Medicine / 2021 / Cilt: 10 - Sayı: 4

The SWaWXV of HealWhcare ProfeVVionalV¶ HaYing COVID-19 Vaccine and Evaluation of Its Side Effects: A Pandemic Hospital Experience

Pages
203–210
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: It was concluded that COVID-19 vaccination differs according to age, gender, and role in the hospital, with the highest vaccination rate among physicians.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Vaccination is one of the most effective and safest preventive health services in the fight against COVID-19.
📊
Key Findings & Data:Many people in society have hesitations about the COVID-19 vaccines.
💡
Conclusion & Impact:Conclusion: It was concluded that COVID-19 vaccination differs according to age, gender, and role in the hospital, with the highest vaccination rate among physicians.
🔬Design:Modeling & Simulation
📍Scope:2021 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Vaccination is one of the most effective and safest preventive health services in the fight against COVID-19. Many people in society have hesitations about the COVID-19 vaccines. We evaluated the vaccination participation rates of healthcare workers to be a positive role model for society. Methods: Between 14 January 2021 and 15 April 2021, 2637 healthcare workers who received 2 doses of 0.5 ml CoronaVac vaccine with 4 weeks intervals were classified as occupation, unit, marital status, age, and gender. Registered side effects were evaluated. Results: It was observed that 65.6% of the healthcare workers were vaccinated and 2.4% (n=62) of the vaccinated workers developed side effects. The mean age of the vaccinated personnel was 34.37±10.04 years. 59.8% (n=1577) of the vaccinated personnel were male and 53.6% (n=1413) were single. The occupational group with the highest vaccination rate was doctors with 78% (n=658). The most common side effect was myalgia in 45.2% (n=28), followed by headache with 38.7% (n=24). About half of those who developed side effects had only one side effect. Conclusion: It was concluded that COVID-19 vaccination differs according to age, gender, and role in the hospital, with the highest vaccination rate among physicians. The vaccination status of healthcare workers who are heavily affected by COVID-19 will positively affect society

🔖

Cite This Article

POLAT, Ö., BERBER, M. (2022). The SWaWXV of HealWhcare ProfeVVionalV¶ HaYing COVID-19 Vaccine and Evaluation of Its Side Effects: A Pandemic Hospital Experience. Eurasian Journal of Family Medicine, Cilt: 10 - Sayı: 4, 203–210. https://ajindex.com/articles/508314

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 2020;5:536–44. doi:10.1038/s41564-020-0695-z
  2. World Health Organization [Internet]. WHO Director-General’s opening remarks at the media briefing on COVID-19-March 2020. [cited 2020 Dec 12]. Available from: https://www.who.int/directorgeneral/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11- march-2020 3. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020;323:1239–42. doi:10.1001/jama.2020.2648
  3. Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis 2020;71(15):732-9. doi:10.1093/cid/ciaa237
  4. Billett HH, Reyes-Gil M, Szymanski J, Ikemura K, Stahl LR, Lo Y, et al. Anticoagulation in COVID-19: Effect of enoxaparin, heparin, and apixaban on mortality. Thromb Haemost 2020;120(12):1691-9. doi: 10.1055/s-0040-1720978
  5. Graham RL, Donaldson EF, Baric RS. A decade after SARS: strategies for controlling emerging coronaviruses. Nat Rev Microbiol 2013;11(12):836–48. doi:10.1038/nrmicro3143
  6. Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, et al. Isolation and characterization of SARSCoV-2 from the first US COVID-19 patient. bioRxiv 2020;2020.03.02.972935. doi:10.1101/2020.03.02.972935. Preprint
  7. Andre FE, Booy R, Bock HL, Clemens J, Datta SK, John TJ, et al. Vaccination greatly reduces disease, disability, death and inequity worldwide. Bull World Health Organ 2008;86(2):140-6. doi: 10.2471/blt.07.040089
  8. Adams JG, Walls RM. Supporting the health care workforce during the COVID-19 global epidemic. JAMA 2020;323(15):1439-40. doi: 10.1001/jama.2020.3972. 10.Turkish Ministry of Health [Internet]. COVID-19 aşısı ulusal uygulama stratejisi [cited 2021 Apr 25]. Available from: https://covid19asi.saglik.gov.tr/TR-77706/covid-19-asisi-ulusal-uygulama-stratejisi.html 11.World Health Organisation [Internet]. Report of the sage working group on vaccine hesitancy [cited 2021 May 01]. Avaible from: https://www.who.int/immunization/sage/me